Dalton Bioanalytics delivers comprehensive multiomics analysis through our revolutionary Omni-MS® platform – the first technology to measure proteins, lipids, metabolites, and small molecules in a single analytical procedure. The multiomics data (Proteomics, metabolomics, lipidomics, and transcriptomics) that Dalton is generating provides researchers with holistic biological insights while reducing time and cost compared to traditional multi-platform approaches.
Our integrated services support biomarker discovery, drug development, and translational research for pharmaceutical companies, research institutions, and government agencies. From sample preration to data analysis, our expert team ensures high-quality, actionable results for every project. They provide the following services: